These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9620990)

  • 21. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Genomic Sequencing and Pathogenic Properties of Equine Herpesvirus 1 KyA and RacL11.
    Shakya AK; O'Callaghan DJ; Kim SK
    Front Vet Sci; 2017; 4():211. PubMed ID: 29312962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate-early protein of equid herpesvirus type 1 as a target for cytotoxic T-lymphocytes in the Thoroughbred horse.
    Kydd JH; Case R; Minke J; Audonnet JC; Wagner B; Antczak DF
    J Gen Virol; 2014 Aug; 95(Pt 8):1783-1789. PubMed ID: 24836672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.
    Nicholas JA; Rubino KL; Levely ME; Adams EG; Collins PL
    J Virol; 1990 Sep; 64(9):4232-41. PubMed ID: 2117070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
    Tewari D; Whalley JM; Love DN; Field HJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.
    Soboll G; Whalley JM; Koen MT; Allen GP; Fraser DG; Macklin MD; Swain WF; Lunn DP
    J Gen Virol; 2003 Oct; 84(Pt 10):2625-2634. PubMed ID: 13679596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
    Breathnach CC; Soboll G; Suresh M; Lunn DP
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
    Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
    Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.
    Kim SK; Shakya AK; O'Callaghan DJ
    Antiviral Res; 2019 Sep; 169():104546. PubMed ID: 31247247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological correlates of vaccination and infection for equine herpesvirus 1.
    Goodman LB; Wimer C; Dubovi EJ; Gold C; Wagner B
    Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E.
    Frampton AR; Smith PM; Zhang Y; Grafton WD; Matsumura T; Osterrieder N; O'Callaghan DJ
    Virus Genes; 2004 Aug; 29(1):9-17. PubMed ID: 15215680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
    J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells.
    Azmi M; Field HJ
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():275-80. PubMed ID: 8381468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
    Kydd JH; Hannant D; Robinson RS; Bryant N; Osterrieder N
    Vaccine; 2020 Jan; 38(2):388-398. PubMed ID: 31629571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice.
    Jones LD; Bennett AM; Moss SR; Gould EA; Phillpotts RJ
    Virus Res; 2003 Feb; 91(2):255-9. PubMed ID: 12573505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.